Share on StockTwits

RBC Life Sciences (NASDAQ:RBCL) CEO Clinton H. Howard bought 5,000 shares of the stock on the open market in a transaction that occurred on Monday, June 16th. The shares were purchased at an average price of $0.60 per share, with a total value of $3,000.00. Following the completion of the transaction, the chief executive officer now directly owns 982,860 shares of the company’s stock, valued at approximately $589,716. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Shares of RBC Life Sciences (NASDAQ:RBCL) opened at 0.75 on Friday. RBC Life Sciences has a 52 week low of $0.01 and a 52 week high of $0.29. The stock has a 50-day moving average of $0.14 and a 200-day moving average of $0.14. The company’s market cap is $1.7 million.

RBC Life Sciences, Inc (NASDAQ:RBCL) is principally engaged in the marketing and distribution of nutritional supplements and personal care products (collectively Nutritional Products) through subsidiaries in the United States and Canada and, effective October 1, 2011, a branch office in Taiwan.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.